ABCA4 RETINOPATHY

Clinical trials for ABCA4 RETINOPATHY explained in plain language.

Never miss a new study

Get alerted when new ABCA4 RETINOPATHY trials appear

Sign up with your email to follow new studies for ABCA4 RETINOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Common diabetes pill could be key to slowing rare blindness

Disease control Recruiting now

This study is testing if the oral diabetes medication metformin is safe and can slow down the progression of ABCA4 retinopathy, a genetic eye disease that causes vision loss. It will involve about 56 participants aged 12 and older who have the disease. Participants will take metf…

Matched conditions: ABCA4 RETINOPATHY

Phase: PHASE1, PHASE2 • Sponsor: National Eye Institute (NEI) • Aim: Disease control

Last updated Mar 20, 2026 14:48 UTC

ABCA4 RETINOPATHY

Get alerted when new ABCA4 RETINOPATHY trials appear

Common diabetes pill could be key to slowing rare blindness